Showing results (71-80 of 193) with videos related to

Sort By:
Pageof 20
Diagnostics (Basel, Switzerland)|December 24, 2021
Comparison of Two Blood-Based Genotyping Tests to Investigate the KRAS G12C Mutation in Patients with Non-Small-Cell Lung Cancer at Failure of First-Line TreatmentsChiara Nicolazzo, Alain Gelibter, Irene Bottillo, et al.
Frontiers in Pharmacology|October 24, 2025
A mixture of postbiotics/tyndallized probiotics reduces trimethylamine (TMA) in trimethylaminuria models: Evidence from in vitro and in vivo studiesGiuseppe Giannini, Sara Soldi, Marina Elli, et al.
Bioorganic & Medicinal Chemistry|October 11, 2005
Targeting integrins: insights into structure and activity of cyclic RGD pentapeptide mimics containing azabicycloalkane amino acidsLaura Belvisi, Anna Bernardi, Matteo Colombo, et al.
Cancer Research|February 28, 2002
retSDR1, a short-chain retinol dehydrogenase/reductase, is retinoic acid-inducible and frequently deleted in human neuroblastoma cell linesFabio Cerignoli, Xiaojia Guo, Beatrice Cardinali, et al.
Neoplasia (New York, N.Y.)|August 2, 2008
Human papilloma virus-dependent HMGA1 expression is a relevant step in cervical carcinogenesisMassimiliano Mellone, Christian Rinaldi, Isabella Massimi, et al.
Breast Cancer Research and Treatment|September 27, 2008
BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central ItalyLaura Ottini, Piera Rizzolo, Ines Zanna, et al.
Oncotarget|February 12, 2015
Preclinical antitumor activity of ST7612AA1: a new oral thiol-based histone deacetylase (HDAC) inhibitorLoredana Vesci, Elena Bernasconi, Ferdinando Maria Milazzo, et al.
European Journal of Medicinal Chemistry|February 19, 2016
Biphenyl-4-yl-acrylohydroxamic acids: Identification of a novel indolyl-substituted HDAC inhibitor with antitumor activityRaffaella Cincinelli, Vincent Zwick, Loana Musso, et al.
Frontiers in Oncology|July 18, 2022
5FU/Oxaliplatin-Induced Jagged1 Cleavage Counteracts Apoptosis Induction in Colorectal Cancer: A Novel Mechanism of Intrinsic Drug ResistanceMaria Pelullo, Sabrina Zema, Mariangela De Carolis, et al.
Plos One|June 14, 2013
Gli2 acetylation at lysine 757 regulates hedgehog-dependent transcriptional output by preventing its promoter occupancySonia Coni, Laura Antonucci, Davide D'Amico, et al.
Pageof 20